Showing results (41-50 of 114) with videos related to
Sort By:
Pageof 12
Journal of Clinical Psychology|July 1, 1984
MMPI correlates of relatively localized brain damageJ A Woodward, C T Bisbee, J E BennettAntimicrobial Agents and Chemotherapy|December 1, 1978
Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicityR B Diasio, D E Lakings, J E BennettJournal of Clinical Microbiology|March 1, 1982
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C)K J Kwon-Chung, I Polacheck, J E BennettClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shuntingM K Park, D R Hospenthal, J E BennettReviews of Infectious Diseases|September 1, 1984
Capsular polysaccharides of Cryptococcus neoformansA K Bhattacharjee, J E Bennett, C P GlaudemansAntimicrobial Agents and Chemotherapy|October 1, 1973
Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosineE R Block, A E Jennings, J E BennettJournal of Pharmacokinetics and Biopharmaceutics|February 1, 1997
Modeling of trough plasma bismuth concentrationsJ E Bennett, J C Wakefield, L F LaceyAntimicrobial Agents and Chemotherapy|October 1, 1986
Bioassay for SF 86-327, a new antifungal agentV L Kan, D K Henderson, J E BennettClinical and Experimental Immunology|September 1, 1986
Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitroD K Henderson, V L Kan, J E BennettAntimicrobial Agents and Chemotherapy|June 1, 1973
5-fluorocytosine resistance in Cryptococcus neoformansE R Block, A E Jennings, J E BennettPageof 12